logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Prostate cancer: ADT and dose-escalated radiotherapy sequence do not matter

Phase 3 trial reports similar recurrence, mortality, and toxicities.